The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with menopause as well as a common breast cancer therapy.

President Donald Trump, who took office on January 20, has promised widespread deregulation, leading US banks to hope they will receive lighter supervision and more generous treatment on a range of ...

“FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator,” Trump wrote in a statement ... across the venture firms tracked by BioPharma Dive, already totals some $2 ...

Last week, Ardent Health purchased 18 urgent care clinics in New Mexico and Oklahoma from NextCare for an undisclosed price. The purchase represents a significant expansion for the for-profit health ...

was the primary payer for 62% of nursing facility residents as of July 2023, according to KFF. “Owners are very engaged in protecting their franchise,” Friedman said. Regulators’ assessment ...

We asked 25 thought leaders in the Asia-Pacific region to share their security predictions and goals for the year.

Good morning, and welcome to the Origin Bancorp Incorporated Fourth Quarter Earnings Conference Call. The format of the call includes prepared remarks from the company, followed by a ...

This week’s roundup highlights the five most-read stories, offering a mix of impactful local news and updates. These stories ...

Kevin Mahn, President & CIO at Hennion & Walsh Asset Management, recently appeared on CNBC on January 6 to discuss the ...

Look closely, it is fast-rising, first-generation business leaders whose companies secure mega contracts who bear the brunt ...

Inc.'s results from ENTRUST study on pegozafermin for Severe Hypertriglyceridemia expected in 2025. Click for this updated ...